Gilead Sciences Stock Price on November 13, 2024
| GILD Stock | USD 92.58 0.17 0.18% |
Below is the normalized historical share price chart for Gilead Sciences extending back to January 22, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gilead Sciences stands at 92.58, as last reported on the 30th of November, with the highest price reaching 93.16 and the lowest price hitting 92.33 during the day.
If you're considering investing in Gilead Stock, it is important to understand the factors that can impact its price. Gilead Sciences appears to be very steady, given 3 months investment horizon. Gilead Sciences holds Efficiency (Sharpe) Ratio of 0.19, which attests that the entity had a 0.19% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Gilead Sciences, which you can use to evaluate the volatility of the firm. Please utilize Gilead Sciences' Market Risk Adjusted Performance of 0.5584, risk adjusted performance of 0.1541, and Downside Deviation of 1.4 to validate if our risk estimates are consistent with your expectations.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 65.2 B, whereas Capital Stock is forecasted to decline to about 901 K. . At present, Gilead Sciences' Price Book Value Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.80, whereas Price To Sales Ratio is forecasted to decline to 3.54. Gilead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of January 1992 | 200 Day MA 75.4308 | 50 Day MA 87.9112 | Beta 0.192 |
Gilead |
Sharpe Ratio = 0.1853
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GILD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.42 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Gilead Sciences is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding it to a well-diversified portfolio.
Price Book 6.234 | Enterprise Value Ebitda 34.0427 | Price Sales 4.0772 | Shares Float 1.2 B | Dividend Share 3.06 |
Related Headline
Enliven Therapeutics Headline on 13th of November 2024
Enliven Therapeutics Reports Third Quarter Financial Results... by finance.yahoo.com
Enliven Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the third quarter ended September 30, 2024, and provided a business update, including highlights of pipeline progress.
Gilead Sciences Valuation on November 13, 2024
It is possible to determine the worth of Gilead Sciences on a given historical date. On November 13, 2024 Gilead was worth 94.13 at the beginning of the trading date compared to the closed value of 92.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gilead Sciences stock. Still, in general, we apply an absolute valuation method to find Gilead Sciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gilead Sciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gilead Sciences' related companies.
| Open | High | Low | Close | Volume | |
| 96.35 | 96.84 | 94.23 | 94.35 | 8,403,821 | |
11/13/2024 | 94.13 | 94.21 | 91.63 | 92.63 | 10,776,010 |
| 92.31 | 92.66 | 91.30 | 92.11 | 8,060,378 |
| Backtest Gilead Sciences | | | Gilead Sciences History | | | Gilead Sciences Valuation | Previous | Next |
Gilead Sciences Trading Date Momentum on November 13, 2024
| On November 14 2024 Gilead Sciences was traded for 92.11 at the closing time. The top price for the day was 92.66 and the lowest listed price was 91.30 . The trading volume for the day was 8.1 M. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.56% . The overall trading delta against the current closing price is 1.84% . |
Gilead Sciences Fundamentals Correlations and Trends
By evaluating Gilead Sciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gilead Sciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gilead financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gilead Sciences Stock history
Gilead Sciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gilead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gilead Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gilead Sciences stock prices may prove useful in developing a viable investing in Gilead Sciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.3 B | 1.5 B | |
| Net Income Applicable To Common Shares | 5.3 B | 4.9 B |
Gilead Sciences Quarterly Net Working Capital |
|
Gilead Sciences Stock Technical Analysis
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Gilead Sciences Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Gilead Sciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Gilead Sciences November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Gilead Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gilead Sciences shares will generate the highest return on investment. By undertsting and applying Gilead Sciences stock market strength indicators, traders can identify Gilead Sciences entry and exit signals to maximize returns
Gilead Sciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gilead Sciences' price direction in advance. Along with the technical and fundamental analysis of Gilead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gilead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1541 | |||
| Jensen Alpha | 0.2016 | |||
| Total Risk Alpha | 0.03 | |||
| Sortino Ratio | 0.0967 | |||
| Treynor Ratio | 0.5484 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |